GO41767
10 Dec 2020
SKYSCRAPER-02
NCT04256421
This study will evaluate the efficacy of tiragolumab plus atezolizumab and carboplatin and etoposide (CE) compared with placebo plus atezolizumab and CE in participants with chemotherapy-naive extensive-stage small cell lung cancer (ES-SCLC).
Hoffmann-La Roche
Cancer Type | Lung & mesothelioma |
---|---|
Trial Type | Treatment |
Phase | Phase III |
Age Range | 18 years and older |
Sex | Both |
Tumour Stream | ES-SCLC |
Cancer Stage | Locally Recurrent or Locally Advanced |
Anticipated Start Date | 2020-02-04 |
Anticipated End Date | - |
Hospital | Lyell McEwin Hospital |
---|---|
Clinical Trial Coordinator | Andy Phay |
andy.phay@sa.gov.au | |
Phone | 08 8282 0833 |
Principal Investigator | Dr Dainik Patel |
Recruitment Status | Recruiting |